Medication info
Huons Metformin Sustained-Release Tablets (Metformin Hydrochloride)

Huons Metformin Sustained-Release Tablets (Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Huons Co., Ltd.
Appearance
White to light yellow rectangular tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200607847 · Notified 2006.08.23 · Insurance code 670605860

Summary

Main use
Treatment of type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose should be determined individually based on response and tolerability, and should not exceed the recommended maximum daily dose. - The usual starting dose is metformin hydrochloride extended-release tablets 500mg once daily with the evening meal. - Measure blood glucose after one week and adjust the dose. Gastrointestinal adverse reactions may improve with gradual dose increases. The maximum dose is 2000mg per day. - When increasing the dose, increase by 500mg each week, up to a maximum of 2000mg per day, taken with the evening meal. If glycemic control is not achieved with a maximum of 2000mg once daily, consider administering 1000mg twice daily; both doses should be taken with meals. - For patients already receiving metformin tablets, the initial dose of this product is the same as the daily dose of immediate-release metformin tablets. Switching to this product is not recommended for patients taking more than 2000mg per day of immediate-release metformin tablets. - At the start of treatment and when adjusting the dose, measure fasting blood glucose to assess the therapeutic response to this medicine and determine the minimum effective dose. Measure blood glycated hemoglobin approximately every 3 months. - The goal of treatment with this medicine, when used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin to normal or near-normal levels using the minimum effective dose. Patients with renal impairment This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~ <60ml/min or glomerular filtration rate (GFR) 45≤~ <60 mL/min/1.73 m2) who have no other condition that may increase the risk of lactic acidosis, with the following dose adjustment: - The starting dose is 500mg or 750mg once daily. The maximum daily dose is 1000mg. Renal function should be monitored closely every 3- 6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73m2, respectively, this medicine must be discontinued immediately.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Type 2 diabetes
View approved original text

This medication helps control blood sugar in patients with type 2 diabetes who cannot sufficiently manage their blood sugar with diet and exercise alone, particularly in those who are overweight. It can be used alone or in combination with other oral hypoglycemic agents or insulin, allowing for flexible treatment options. This helps effectively manage blood sugar levels and contributes to the prevention of diabetes-related complications.

How to take

Adult dose

The dose should be determined individually based on response and tolerability, and should not exceed the recommended maximum daily dose. - The usual starting dose is metformin hydrochloride extended-release tablets 500mg once daily with the evening meal. - Measure blood glucose after one week and adjust the dose. Gastrointestinal adverse reactions may improve with gradual dose increases. The maximum dose is 2000mg per day. - When increasing the dose, increase by 500mg each week, up to a maximum of 2000mg per day, taken with the evening meal. If glycemic control is not achieved with a maximum of 2000mg once daily, consider administering 1000mg twice daily; both doses should be taken with meals. - For patients already receiving metformin tablets, the initial dose of this product is the same as the daily dose of immediate-release metformin tablets. Switching to this product is not recommended for patients taking more than 2000mg per day of immediate-release metformin tablets. - At the start of treatment and when adjusting the dose, measure fasting blood glucose to assess the therapeutic response to this medicine and determine the minimum effective dose. Measure blood glycated hemoglobin approximately every 3 months. - The goal of treatment with this medicine, when used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin to normal or near-normal levels using the minimum effective dose. Patients with renal impairment This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~ <60ml/min or glomerular filtration rate (GFR) 45≤~ <60 mL/min/1.73 m2) who have no other condition that may increase the risk of lactic acidosis, with the following dose adjustment: - The starting dose is 500mg or 750mg once daily. The maximum daily dose is 1000mg. Renal function should be monitored closely every 3- 6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73m2, respectively, this medicine must be discontinued immediately.

Precautions

This medication can rarely cause a serious condition called lactic acidosis, so one should be well aware of this symptom. Lactic acidosis is a condition where lactic acid accumulates excessively in the body, which can be life-threatening if not treated quickly. Additionally, when this medication is used in combination with other diabetes medications, there may be a risk of hypoglycemia, so blood sugar levels should be monitored closely. Patients with moderate to severe renal impairment, dehydration, acute conditions such as severe infections, or heart failure should not use this medication because renal function plays a crucial role in the drug's excretion, and decreased function increases the risk of side effects due to drug accumulation in the body. Patients who are scheduled to undergo tests with iodine contrast agents should temporarily suspend taking this medication before and after the test and only resume after confirming normal renal function. Patients with allergies to any ingredients of this medication, type 1 diabetes, diabetic ketoacidosis, severe infections, or liver dysfunction should also avoid using this medication. While using this medication, caution is needed due to the increased risk of lactic acidosis and hypoglycemia with irregular meals, excessive exercise, or taking interacting medications. This medication may cause side effects such as gastrointestinal disturbances, vitamin B12 deficiency, altered taste, etc., with gastrointestinal symptoms commonly occurring initially but improving over time. Regular checks of renal function as well as blood sugar and vitamin B12 levels are necessary to ensure there are no abnormalities, and any concerning symptoms should be reported to healthcare professionals immediately. During pregnancy, careful consideration is necessary due to the potential impact on the fetus, and during breastfeeding, as this medication is excreted in breast milk, careful decisions should be made about breastfeeding and whether to interrupt treatment. Elderly patients are more likely to have decreased renal function, so dosage adjustment and regular monitoring of renal function should be conducted. In the case of overdose, blood dialysis can be used to remove the drug, so care should be taken not to exceed the prescribed dosage. This medication may interact with other drugs, so if you are taking any other medications, you must inform your healthcare provider, especially when using drugs that can affect blood sugar control.

Side effects

  • Lactic acidosis
  • severe hypoglycemia
  • vitamin B12 deficiency
  • taste disturbances
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • erythema
Show 3 more
  • pruritus
  • urticaria
  • rash

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air exposure and kept in a cool place below 25 degrees Celsius. Proper storage can help maintain the medication's effectiveness for a longer time.

Appearance and packaging

Appearance

White to light yellow rectangular tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.